Efficacy of 5-Day Levofloxacin-Containing Concomitant Therapy in Eradication of Helicobacter pylori Infection (original) (raw)
P.28 LEVOFLOXACIN-BASED SEQUENTIAL THERAPY VS CLARITHROMYCIN-BASED SEQUENTIAL THERAPY FOR ERADICATION OF H. PYLORI INFECTION
Antonietta Gravina
Digestive and Liver Disease, 2010
View PDFchevron_right
Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial
Riccardo Marmo
Gut, 2010
View PDFchevron_right
Levofloxacin versus clarithromycin in a 10 day triple therapy regimen for first-line Helicobacter pylori eradication: a single-blind randomized clinical trial
Miguel Carrascosa
Journal of Antimicrobial Chemotherapy, 2012
View PDFchevron_right
Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial
Marcello Candelli
Alimentary Pharmacology and Therapeutics, 2003
View PDFchevron_right
Comparison of Levofloxacin-Based, 10-day Sequential Therapy with 14-day Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Clinical Trial
Eskandar Hajiani
Middle East Journal of Digestive Diseases
View PDFchevron_right
Levofloxacin/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second-line
Lucia Fini
World Journal of Gastroenterology, 2012
View PDFchevron_right
The Clinical and Bacteriological Factors for Optimal Levofloxacin-Containing Triple Therapy in Second-Line Helicobacter pylori Eradication
Keng-liang Wu
PLoS ONE, 2014
View PDFchevron_right
Levofloxacin-Based Triple Therapy in First-Line Treatment for Helicobacter pylori Eradication
Marcello Candelli
The American Journal of Gastroenterology, 2006
View PDFchevron_right
Efficacy and tolerability of a third-line, levofloxacin-based, 10-day sequential therapy in curing resistant Helicobacter pylori infection
Antonio Tursi
Journal of gastrointestinal and liver diseases : JGLD, 2012
View PDFchevron_right
A Comparative Study of Sequential Therapy and Standard Triple Therapy for Helicobacter pylori Infection: A Randomized Multicenter Trial
Minhu Chen
The American Journal of Gastroenterology, 2014
View PDFchevron_right
Seven-day PPI-triple therapy with levofloxacin is very effective for Helicobacter pylori eradication
Wink De Boer
The Netherlands Journal of Medicine
View PDFchevron_right
First- and second-line Helicobacter pylori eradication with modified sequential therapy and modified levofloxacin-amoxicillin-based triple therapy
Cesare Efrati, Lorenzo Ridola, Domenico Alvaro
Annals of gastroenterology : quarterly publication of the Hellenic Society of Gastroenterology, 2014
View PDFchevron_right
Comparison of levofloxacin-containing sequential and standard triple therapies for the eradication of Helicobacter pylori
Murat Kantarcioglu
European Journal of Internal Medicine, 2012
View PDFchevron_right
Levofloxacin-based sequential therapy versus classic triple therapy in Helicobacter pylori eradication: A randomized clinical trial
Parastoo Baharvand
Biomedical Research and Therapy
View PDFchevron_right
Standard triple versus levofloxacin based regimen for eradication of Helicobacter pylori
Jagdish Sadasivan
World Journal of Gastrointestinal Pharmacology and Therapeutics, 2013
View PDFchevron_right
2-Week Triple Therapy for Helicobacter pylori Infection is Better Than 1-Week in Clinical Practice: a Large Prospective Single-Center Randomized Study
Federico Iacopini
Helicobacter, 2006
View PDFchevron_right
Efficacy of H. pylori eradication with a sequential regimen followed by rescue therapy in clinical practice
Rita Angelini
Digestive and Liver Disease, 2010
View PDFchevron_right
The Efficacy of Levofloxacin-based Triple Therapy for First-line Helicobacter Pylori Eradication
hajrullah fejza
Medical Archives, 2013
View PDFchevron_right
Comparison of Two Commonly Used Sequential Therapy Regimens for Eradication of Helicobacter Pylori Infection
feroz wani
International Journal of Advanced Research
View PDFchevron_right
Comparison of the Efficacy of 12-day Concomitant Quadruple Therapy versus 14-day High dose Dual Therapy as a First-line H. pylori Eradication Regimen
Seyed Mohammad Valizadeh Toosi
The Korean journal of gastroenterology, 2024
View PDFchevron_right
Comparison of concomitant therapy versus standard triple-drug therapy for eradication of Helicobacter pylori infection: A prospective open-label randomized controlled trial
Ravish Ranjan
Indian Journal of Gastroenterology, 2019
View PDFchevron_right
Sequential and Concomitant Therapy With Four Drugs Is Equally Effective for Eradication of H pylori Infection
Antone Opekun
Clinical Gastroenterology and Hepatology, 2010
View PDFchevron_right
Concomitant, sequential, and hybrid therapy for H. pylori eradication: A pilot study
Valentina Ruggiero
Clinics and Research in Hepatology and Gastroenterology, 2013
View PDFchevron_right
Reevaluation of the Efficacy of First Line Regimen for Helicobacter pylori
Umar Kamal
Clinical and Experimental Gastroenterology, 2020
View PDFchevron_right
Efficacy of standard triple therapy versus Levofloxacin based alternate therapy against Helicobacter pylori infection
waqas maqsood
JPMA. The Journal of the Pakistan Medical Association, 2018
View PDFchevron_right
Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design
Chi-yang Chang
Gut, 2010
View PDFchevron_right
A Randomized Controlled Trial: Efficacy and Safety of Azithromycin, Ofloxacin, Bismuth, and Omeprazole Compared With Amoxicillin, Clarithromycin, Bismuth, and Omeprazole as Second-Line Therapy in Patients With Helicobacter pylori Infection
Mohammad Minakari
Helicobacter, 2010
View PDFchevron_right
Levofloxacin based triple therapy as a second-line treatment after failure of Helicobacter pylori eradication with standard triple therapy
Casmir Wambura
Digestive and Liver Disease, 2003
View PDFchevron_right
Ten-day triple therapyversussequential therapyversusconcomitant therapy as first-line treatment forHelicobacter pyloriinfection
Jessica Rey Tan
Journal of Gastroenterology and Hepatology, 2015
View PDFchevron_right